TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701 ...
Rights May 31, 2023 May 31, 2023 Apr 22, 2022 Rights ratio: 1 share for every 2 held at a price of Rs 12.0 Bonus Oct 04, 2019 Oct 07, 2019 Aug 26, 2019 Bonus Ratio: 15 share(s) for every 100 shares ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback